To the best of our knowledge, this is a full‐scale study of such a topic in the PD biomarker fields, and we detail baseline plasma MAP (e.g., PINK1, Parkin, and PGAM5) levels of PD and PDs compared with healthy controls. This evidence concerns the gene PGAM5 and Parkinson disease.